Hubscher T
J Immunol. 1975 Apr;114(4):1389-93.
Human eosinophilic leukocytes respond to a variety of stimuli by liberating an inhibitor of histamine release. The active principle(s) in this eosinophil-derived inhibitor (EDI) was found to be a mixture of acidic lipids of similar physiocochemical behavior and biologic activity to prostaglandins E1 and E2. Indomethacin, an inhibitor or prostaglandin synthesis, specifically blocked the immune release of EDI. The results indicate that stimulation of human eosinophilic leukocytes results in synthesis and release of prostaglandins E1 and E2 from these cells. These findings strongly support the hypothesis that the eosinophil assumes a modulatory role in the allergic inflammatory reaction. The ways by which, under specific antigenic (allergenic) stimulation, human eosinophils could modulate the events asssociated with the allergic response, through the released prostaglandins, are discussed.
人类嗜酸性白细胞通过释放组胺释放抑制剂对多种刺激作出反应。在这种嗜酸性粒细胞衍生抑制剂(EDI)中的活性成分被发现是一种酸性脂质混合物,其物理化学行为和生物活性与前列腺素E1和E2相似。吲哚美辛,一种前列腺素合成抑制剂,特异性地阻断了EDI的免疫释放。结果表明,对人类嗜酸性白细胞的刺激导致这些细胞合成并释放前列腺素E1和E2。这些发现有力地支持了嗜酸性粒细胞在过敏性炎症反应中起调节作用的假说。本文讨论了在特定抗原(变应原)刺激下,人类嗜酸性粒细胞如何通过释放的前列腺素调节与过敏反应相关的事件。